该产品被引用文献
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer
Rachner, Kasimir-Bauer, Goebel, Erdmann, Hoffmann, Rauner, Hofbauer, Kimmig, Bittner
J Cancer Res Clin Oncol (2021) 147 (8), 2233-2238 DOI: 10.1007/s00432-021-03635-1
PMID: 33884469
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer. Rachner TD, Kasimir-Bauer S, Goebel A, Erdmann K, Hoffmann O, Rauner M, Hofbauer LC, Kimmig R, Bittner AK. J Cancer Res Clin Oncol. 2021. Apr 21. doi: 10.1007/s00432-021-03635-1. Epub ahead of print. PMID: 33884469.
Characterization of a sandwich ELISA for quantification of total human soluble neuropilin-1. Gadermaier E, Tesarz M, Wallwitz J, Berg G, Himmler G. J Clin Lab Anal. 2019 Sep;33(7):e22944. doi: 10.1002/jcla.22944. Epub 2019 Jun 20. PMID: 31219204; PMCID: PMC6757120.
Characterization of a sandwich ELISA for quantification of total human soluble neuropilin-1.Gadermaier, E., Tesarz, M., Wallwitz, J., Berg, G., Himmler, G., 2019. Journal of Clinical Laboratory Analysis, e22944.
PMID: 31219204
Quantification of soluble human Neuropilin-1 by sandwich ELISA. Tesarz, M., Gadermaier, E., Ho, T.T.O., Berg, G., Himmler, G., n.d. p. 1